Organization Profile

You just read:

NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder

News provided by

NeuroSigma, Inc.

May 02, 2013, 06:06 ET